- Home
- MREO vs MPB Comparison
MREO vs MPB Comparison
Compare MREO & MPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MREO | MPB |
|---|---|---|
| Founded | 2015 | 1868 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 738.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MREO | MPB |
|---|---|---|
| Price | $2.30 | $31.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $7.20 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 2.6M | 92.9K |
| Earning Date | 11-10-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.74% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.40 |
| Revenue | $500,000.00 | ★ $208,869,000.00 |
| Revenue This Year | N/A | $26.19 |
| Revenue Next Year | $163.84 | $28.25 |
| P/E Ratio | ★ N/A | $13.21 |
| Revenue Growth | N/A | ★ 20.73 |
| 52 Week Low | $1.47 | $22.50 |
| 52 Week High | $3.88 | $33.24 |
Technical Indicators
Market Signals| Indicator | MREO | MPB |
|---|---|---|
| Relative Strength Index (RSI) | 63.51 | 59.99 |
| Support Level | $1.89 | $31.64 |
| Resistance Level | $2.36 | $33.24 |
| Average True Range (ATR) | 0.15 | 0.63 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 85.57 | 56.77 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.